Concordance between local, institutional, and central pathology review in glioblastoma: Implications for research and practice: A pilot study

Neurology India

Volumn 60, Issue 1, 2012, Pages 61-65

  Gupta, Tejpal ^a   Nair, Vimoj ^a   Epari, Sridhar ^a   Pietsch, Torsten ^b   Jalali, Rakesh ^a  

^a TATA MEMORIAL HOSPITAL   (India)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Agreement; central review; concordance; glioblastoma; grade

Indexed keywords

ASTROCYTOMA; CANCER DIAGNOSIS; CANCER GRADING; CEREBELLUM TENTORIUM; CHEMORADIOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; GLIOBLASTOMA; GLIOSARCOMA; HISTOPATHOLOGY; HUMAN; INSTITUTIONAL REVIEW; INTERRATER RELIABILITY; KAPPA STATISTICS; MEDICAL PRACTICE; OLIGODENDROGLIOMA; PILOT STUDY; PROSPECTIVE PAYMENT; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REVIEW; TERTIARY HEALTH CARE;

BRAIN NEOPLASMS; COHORT STUDIES; FEMALE; GLIOBLASTOMA; HUMANS; INSTITUTIONAL PRACTICE; MALE; OBSERVER VARIATION; PATHOLOGY, CLINICAL; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS;

EID: 84859203099     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.93594     Document Type: Review

References (10)

1. Central Brain Tumor Registry of the United States (CBTRUS) Statistical Report 2005-2006. Primary brain tumors in the United States:1998-2002: Hinsdale, IL.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109.
4. Bruner JM, Inouye L, Fuller GN, Langford LA. Diagnostic discrepancies and their clinical impact in a neuropathology referral practice. Cancer 1997;79:796-803.
5. van den Bent MJ. Interobserver variation of the histopathological diagnosis in clinical trials on glioma: A clinician's perspective. Acta Neuropathol 2010;120:297-304.
6. Teot LA, Sposto R, Khayat A, Qualman S, Reaman G, Parham D. The problems and promise of central pathology review: Development of a standardized procedure for the Children's Oncology Group. Pediatr Dev Pathol 2007;10:199-207.
7. Aldape K, Simmons ML, Davis RL, Miike R, Wiencke J, Barger G, et al. Discrepancies in diagnoses of neuroepithelial neoplasms: The San Francisco Bay Area Adult Glioma Study. Cancer 2000;88:2342-9.
8. Davis FG, Malmer BS, Aldape K, Barnholtz-Sloan JS, Bondy ML, Brannstrom T, et al. Issues of diagnostic review in brain tumor studies: From the Brain Tumor Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev 2008;17:484-9.
9. Scott CB, Nelson JS, Farnan NC, Curran WJ Jr., Murray KJ, Fischbach AJ, et al. Central pathology review in clinical trials for patients with malignant glioma. A Report of Radiation Therapy Oncology Group 83-02. Cancer 1995;76:307-13.
10. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010;17:98-110.